Carregant...
The interaction between RUNX2 and core binding factor beta (CBFβ) as a potential therapeutic target in canine osteosarcoma
Osteosarcoma remains the most common primary bone tumor in dogs with half of affected dogs unable to survive one year beyond diagnosis. New therapeutic options are needed to improve outcomes for this disease. Recent investigations into potential therapeutic targets have focused on cell surface molec...
Guardat en:
| Publicat a: | Vet Comp Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7233265/ https://ncbi.nlm.nih.gov/pubmed/31381810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/vco.12526 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|